Straumann (OTCMKTS:SAUHY) Sees Unusually-High Trading Volume – Here’s Why

Straumann Holding AG (OTCMKTS:SAUHYGet Free Report) saw strong trading volume on Thursday . 60,974 shares were traded during trading, a decline of 1% from the previous session’s volume of 61,644 shares.The stock last traded at $12.16 and had previously closed at $12.42.

Analyst Ratings Changes

SAUHY has been the topic of a number of analyst reports. Citigroup restated a “sell” rating on shares of Straumann in a research note on Wednesday. UBS Group raised shares of Straumann from a “sell” rating to a “neutral” rating in a research note on Tuesday, November 4th. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research report on Monday, December 15th. The Goldman Sachs Group downgraded Straumann from a “strong-buy” rating to a “neutral” rating in a report on Monday, October 13th. Finally, Deutsche Bank Aktiengesellschaft raised Straumann from a “hold” rating to a “buy” rating in a report on Friday, October 31st. Two analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Straumann has an average rating of “Hold”.

Check Out Our Latest Analysis on SAUHY

Straumann Stock Performance

The firm has a 50 day moving average price of $11.97 and a 200-day moving average price of $11.98.

Straumann Company Profile

(Get Free Report)

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.

Featured Stories

Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.